pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 17·1 min read
save

Medicare proposal would boost doctor pay for smoking and alcohol counseling by 19%

Jul 17, 2026·read at STAT ↗RegulatoryPositive

A proposed change to Medicare’s physician fee schedule would increase reimbursement for doctors who provide counseling on tobacco cessation and alcohol or substance misuse.

The proposal adds a 19% payment boost for visits that include counseling on quitting cigarettes or other tobacco products, as well as for assessments and interventions related to alcohol and substance use.

The change is intended to reflect the clinical intensity of these services and encourage more physicians to address these leading causes of preventable disease.

The proposal is part of a broader effort to prioritize cessation services, but it remains a draft within a 1,592‑page Medicare document and has not yet been finalized.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Quitting smoking is hard. A Medicare change may push doctors to give more help”

read at STAT ↗
1,129 words · retrieved Jul 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGPFIZER
drugs
bupropionnicotinenicotine ERvarenicline
topics
Approval2Oncology2Psychiatry & CNSPulmonologyType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT
  • May 12GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026onclive
  • 9h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • 3d agoA winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT